Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Thrombosis Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.thromres.2012.11.002PMID 23199547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.

  2012cited by this paper
• Adverse effects of heparin.

  2012cited by this paper
• Antithrombotic effect of grape seed proanthocyanidins extract in a rat model of deep vein thrombosis.

  2011cited by this paper
• Toll-Like Receptor 9 Signaling Is Critical for Early Experimental Deep Vein Thrombosis Resolution

  2011cited by this paper
• FDA approves rivaroxaban for prevention of deep-vein thrombosis in surgery.

  2011cited by this paper
• Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study.

  2011cited by this paper
• Deep vein thrombosis.

  2010cited by this paper
• Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation

  2010cited by this paper
• Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation

  2010cited by this paper
• Ultrasound-Assisted Thrombolysis for Stroke Therapy: Better Thrombus Break-Up With Bubbles

  2010cited by this paper
• Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.

  2010cited by this paper
• Inferior Vena Cava Ligation Rapidly Induces Tissue Factor Expression and Venous Thrombosis in Rats

  2009cited by this paper
• Evaluation of a prolonged prothrombin time.

  2008cited by this paper
• Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.

  2008cited by this paper
• Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

  2008cited by this paper
• Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis

  2007cited by this paper
• Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.

  2007cited by this paper
• Improving the biocompatibility of in vivo sensors via nitric oxide release.

  2006cited by this paper
• Targeted Deletion of CCR2 Impairs Deep Vein Thombosis Resolution in a Mouse Model12

  2006cited by this paper
• Endothelial nitric oxide synthase: host defense enzyme of the endothelium?

  2005cited by this paper
• Nitric oxide-eluting polyurethanes--vascular grafts of the future?

  2005cited by this paper
• Nitric oxide-producing polyurethanes.

  2005influential reference
• Prevention of venous thromboembolism.

  2005cited by this paper
• Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling.

  2004cited by this paper
• Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model

  2004cited by this paper
• Ultrasound for the Visualization and Quantification of Tumor Microcirculation

  2004cited by this paper
• Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts.

  2004cited by this paper
• Deep vein thrombosis resolution is not accelerated with increased neovascularization.

  2004cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream.

  2002cited by this paper
• Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation.

  2001cited by this paper
• Nitric oxide insufficiency, platelet activation, and arterial thrombosis.

  2001cited by this paper
• Improving the thromboresistivity of chemical sensors via nitric oxide release: fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters.

  2000cited by this paper
• A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis.

  1999cited by this paper
• Changes in the Levels of Soluble Adhesion Molecules and Coagulation Factors in Patients with Deep Vein Thrombosis

  1999cited by this paper
• Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model.

  1998cited by this paper
• Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.

  1997cited by this paper
• Effect of nitric oxide synthase inhibition on bleeding time in humans.

  1995cited by this paper
• Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules.

  1995cited by this paper
• The Emerging Multifaceted Roles of Nitric Oxide

  1995cited by this paper
• The surprising life of nitric oxide

  1993cited by this paper
• Regulation of Vascular Homeostasis by Nitric Oxide

  1993cited by this paper
• Dynamics of the protein metabolic response to burn injury.

  1988cited by this paper
• The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

  1987cited by this paper
• HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Effects

  year unknowncited by this paper

• Multifunctional Ultrasound Microbubbles.

  2026cites this paper
• Dual oxygen supply system of carbon dot-loaded microbubbles with acoustic cavitation for enhanced sonodynamic therapy in diabetic wound healing.

  2025cites this paper
• Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy

  2023cites this paper
• Microbubbles for human diagnosis and therapy.

  2023cites this paper
• The combination of EGCG with warfarin reduces deep vein thrombosis in rabbits through modulating HIF-1α and VEGF via the PI3K/AKT and ERK1/2 signaling pathways.

  2022cites this paper
• Localized Delivery of Caveolin-1 Peptide Assisted by Ultrasound-Mediated Microbubble Destruction Potentiates the Inhibition of Nitric Oxide-Dependent Vasodilation Response.

  2021cites this paper
• Advances in Research on Raman Spectrum Characteristic Peak and Related Analytical Methods of High-content Compositions in Medicinal Soybean Phospholipid

  2021cites this paper
• Targeted Delivery of Therapeutic Gas by Microbubbles

  2021cites this paper
• Cotinine inhibits TLR4/NF-κB signaling pathway and improves deep vein thrombosis in rats

  2020cites this paper
• Bactericidal Activity of Lipid-Shelled Nitric Oxide-Loaded Microbubbles

  2020cites this paper
• Precise treatment of acute antibody-mediated cardiac allograft rejection in rats using C4d-targeted microbubbles loaded with nitric oxide.

  2020cites this paper
• Ultrasound‐mediated therapies for the treatment of biofilms in chronic wounds: a review of present knowledge

  2019influential citation
• Characterization and Imaging of Lipid-Shelled Microbubbles for Ultrasound-Triggered Release of Xenon

  2019cites this paper
• Novel microspheres reduce the formation of deep venous thrombosis and repair the vascular wall in a rat model

  2017cites this paper
• Lipid-based carriers for controlled delivery of nitric oxide

  2017influential citation
• S-Nitrosothiols as Platforms for Topical Nitric Oxide Delivery.

  2016cites this paper
• Danhong huayu koufuye prevents deep vein thrombosis through anti-inflammation in rats.

  2016cites this paper
• Hydrogen sulfide exerts antithrombotic effects and inhibits deep vein thrombosis through NOS-PECAM-1 signaling pathway

  2016cites this paper
• Inhibitory effect of epirubicin-loaded lipid microbubbles with conjugated anti-ABCG2 antibody combined with therapeutic ultrasound on multiple myeloma cancer stem cells

  2016cites this paper
• NOVEL SUBCUTANEOUS SUSTAINED RELEASE NANOPARTICLES ENCAPSULATING LOW MOLECULAR WEIGHT HEPARIN (LMWH): PREPARATION, CHARACTERIZATION AND EVALUATION

  2016cites this paper
• Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis.

  2016cites this paper
• Endothelial progenitor cells accelerate the resolution of deep vein thrombosis.

  2016cites this paper
• Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).

  2016cites this paper
• Therapeutic gas delivery via microbubbles and liposomes.

  2015cites this paper
• Deep venous thrombosis in the nonoperated leg after primary major lower extremity arthroplasty: a retrospective study based on diagnosis using venography

  2015cites this paper
• Detection of targets and their mechanisms for early diagnosis of traumatic deep vein thrombosis.

  2015cites this paper
• Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis

  2014cites this paper
• The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases.

  2013influential citation
• Reply: To PMID 23481505.

  2013cites this paper